BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26005715)

  • 21. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
    Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
    Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for breast cancer according to estrogen and progesterone receptor status.
    Colditz GA; Rosner BA; Chen WY; Holmes MD; Hankinson SE
    J Natl Cancer Inst; 2004 Feb; 96(3):218-28. PubMed ID: 14759989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer Cells.
    Verde G; De Llobet LI; Wright RHG; Quilez J; Peiró S; Le Dily F; Beato M
    Cancers (Basel); 2018 Oct; 10(10):. PubMed ID: 30301163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan).
    Yoo K; Tajima K; Park S; Kang D; Kim S; Hirose K; Takeuchi T; Miura S
    Cancer Lett; 2001 Jun; 167(1):57-63. PubMed ID: 11323099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
    Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
    Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.
    White AJ; Chen J; McCullough LE; Xu X; Cho YH; Teitelbaum SL; Neugut AI; Terry MB; Hibshoosh H; Santella RM; Gammon MD
    Cancer Causes Control; 2015 Dec; 26(12):1791-802. PubMed ID: 26407953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
    Vrieling A; Buck K; Kaaks R; Chang-Claude J
    Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
    Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
    Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between pre-diagnosis recreational physical activity and risk of breast cancer recurrence: the California Teachers Study.
    Lin D; Thompson CL; Demalis A; Derbes R; Al-Shaar L; Spielfogel ES; Sturgeon KM
    Cancer Causes Control; 2024 Apr; ():. PubMed ID: 38613744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.
    Callahan CL; Wang Y; Marian C; Weng DY; Eng KH; Tao MH; Ambrosone CB; Nie J; Trevisan M; Smiraglia D; Edge SB; Shields PG; Freudenheim JL
    Epigenetics; 2016 Sep; 11(9):643-652. PubMed ID: 27245195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of prediagnostic recreational physical activity on survival from breast cancer.
    Cleveland RJ; Eng SM; Stevens J; Bradshaw PT; Teitelbaum SL; Neugut AI; Gammon MD
    Eur J Cancer Prev; 2012 Jan; 21(1):46-54. PubMed ID: 21946863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease.
    Minicozzi P; Berrino F; Sebastiani F; Falcini F; Vattiato R; Cioccoloni F; Calagreti G; Fusco M; Vitale MF; Tumino R; Sigona A; Budroni M; Cesaraccio R; Candela G; Scuderi T; Zarcone M; Campisi I; Sant M
    Eur J Cancer; 2013 Dec; 49(18):3881-8. PubMed ID: 24011933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation and hormone receptor status in breast cancer.
    Benevolenskaya EV; Islam AB; Ahsan H; Kibriya MG; Jasmine F; Wolff B; Al-Alem U; Wiley E; Kajdacsy-Balla A; Macias V; Rauscher GH
    Clin Epigenetics; 2016; 8():17. PubMed ID: 26884818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone receptor status modifies the association between body mass index and prognosis in women diagnosed with estrogen receptor positive breast cancer.
    Oudanonh T; Nabi H; Ennour-Idrissi K; Lemieux J; Diorio C
    Int J Cancer; 2020 May; 146(10):2736-2745. PubMed ID: 31403177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation modifies the association between obesity and survival after breast cancer diagnosis.
    McCullough LE; Chen J; Cho YH; Khankari NK; Bradshaw PT; White AJ; Garbowski G; Teitelbaum SL; Terry MB; Neugut AI; Hibshoosh H; Santella RM; Gammon MD
    Breast Cancer Res Treat; 2016 Feb; 156(1):183-94. PubMed ID: 26945992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma.
    Vincze B; Kapuvári B; Udvarhelyi N; Horváth Z; Mátrai Z; Czeyda-Pommersheim F; Kőhalmy K; Kovács J; Boldizsár M; Láng I; Kásler M
    Springerplus; 2015; 4():387. PubMed ID: 26240785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of reproductive history with breast tissue characteristics and receptor status in the normal breast.
    Gabrielson M; Chiesa F; Behmer C; Rönnow K; Czene K; Hall P
    Breast Cancer Res Treat; 2018 Aug; 170(3):487-497. PubMed ID: 29603032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.